1. Home
  2. IMKTA vs HRMY Comparison

IMKTA vs HRMY Comparison

Compare IMKTA & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ingles Markets Incorporated

IMKTA

Ingles Markets Incorporated

HOLD

Current Price

$83.78

Market Cap

1.6B

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$28.09

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMKTA
HRMY
Founded
1963
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
IMKTA
HRMY
Price
$83.78
$28.09
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$46.70
AVG Volume (30 Days)
105.4K
1.1M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
0.78%
N/A
EPS Growth
N/A
7.97
EPS
N/A
2.71
Revenue
$5,334,032,609.00
$868,453,000.00
Revenue This Year
N/A
$19.87
Revenue Next Year
N/A
$12.49
P/E Ratio
$15.91
$10.28
Revenue Growth
N/A
21.51
52 Week Low
$59.09
$25.52
52 Week High
$90.49
$40.87

Technical Indicators

Market Signals
Indicator
IMKTA
HRMY
Relative Strength Index (RSI) 48.73 35.55
Support Level $68.58 $27.66
Resistance Level $90.24 $28.99
Average True Range (ATR) 2.55 0.81
MACD -0.51 0.23
Stochastic Oscillator 51.33 44.26

Price Performance

Historical Comparison
IMKTA
HRMY

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: